The usefulness of p57 KIP22 immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole

Pathology Research and Practice

Volumn 207, Issue 8, 2011, Pages 498-504

  Landolsi, Hanène ^a,b   Missaoui, Nabiha ^a,b   Brahem, Sonia ^a   Hmissa, Sihem ^a,b   Gribaa, Moez ^a   Yacoubi, Mohamed Tahar ^a,b  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITY OF SOUSSE   (Tunisia)

Author keywords

Complete hydatidiform mole; DNA genotyping; Hydropic abortus; P57 KIP22; Partial hydatidiform mole

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C;

ABORTION; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FETUS; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MICROSATELLITE MARKER; PROTEIN EXPRESSION; TUNISIA;

CYCLIN-DEPENDENT KINASE INHIBITOR P57; FEMALE; GENOTYPE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; PREGNANCY; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 80051800941     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.06.004     Document Type: Article

References (38)

1. Bateman A.C., Hemmatpour S.K., Theaker J.M., et al. Genetic analysis of hydatidiform moles in paraffin embedded tissue using rapid, sequence-specific PCR-based HLA class II typing. J. Clin. Pathol. 1997, 50:288-293.
2. Castrillon D.H., Sun D., Weremowicz S., et al. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am. J. Surg. Pathol. 2001, 25:1225-1230.
3. Chilosi M., Piazzola E., Lestani M., et al. Differential expression of p57KIP2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab. Invest. 1998, 78:269-276.
4. Crisp H., Burton J.L., Stewart R., et al. Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry. Histopathology 2003, 43:363-373.
5. Fisher R.A., Nucci M.R., Thaker H.M., et al. Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. Mod. Pathol. 2004, 17:1155-1160.
6. Fujita N., Tamura S., Shimizu N., et al. Genetic origin analysis of hydatidiform mole and non-molar abortion using the polymerase chain reaction method. Acta Obstet. Gynecol. Scand. 1994, 73:719-725.
7. Fukunaga M. Early partial hydatidiform mole: prevalence, histopathology, DNA ploidy, and persistence rate. Virchows Arch. 2000, 437:180-184.
8. Fukunaga M. Immunohistochemical characterization of p57KIP2 expression in early hydatidiform moles. Hum. Pathol. 2002, 33:1188-1192.
9. Fukunaga M., Katabuchi H., Nagasaka T., et al. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am. J. Surg. Pathol. 2005, 29:942-947.
10. Genest D.R., Dorfman D.M., Castrillon D.H. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification. J. Reprod. Med. 2002, 47:342-346.
11. Hayati A.R., Tan G.C. Clinicopathologic and immunohistochemical differences in complete and partial hydatidiform moles in a multiracial Malaysian population. Int. J. Gynecol. Pathol. 2005, 24:277-285.
12. Hoffner L., Dunn J., Esposito N., et al. p57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions. Hum. Pathol. 2008, 39:63-72.
13. Jackson D.P., Lewis F.A., Taylor G.R., et al. Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. J. Clin. Pathol. 1990, 43:499-504.
14. Jacobs P.A., Wilson C.M., Sprenkle J.A., et al. Mechanism of origin of complete hydatidiform moles. Nature 1980, 286:714-716.
15. Jun S.-Y., Ro J.Y., Kim K.-R. p57KIP2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Histopathology. 2003, 43:17-25.
16. Kajii T., Ohama K. Androgenetic origin of hydatidiform mole. Nature 1977, 268:633-634.
17. Kihara M., Matsui H., Seki K., et al. Genetic origin and imprinting in hydatidiform moles. Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2. J. Reprod. Med. 2005, 50:307-312.
18. Lage J.M., Mark S.D., Roberts D.J., et al. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet. Gynecol. 1992, 79:403-410.
19. Lai C.Y., Chan K.Y., Khoo U.S., et al. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod. Pathol. 2004, 17:40-48.
20. Laitinen J., Samarut J., Hölttä E. A nontoxic and versatile protein salting out method for isolation of DNA. Biotechniques 1994, 17:320-322. 316, 318.
21. Landolsi H., Missaoui N., Trabelsi A., et al. Assessment of the role of histopathology and DNA image analysis in the diagnosis of molar and non molar abortion: a study of 89 cases in the center of Tunisia. Pathol. Res. Pract. 2009, 205:789-796.
22. Lawler S.D., Fisher R.A., Dent J. A prospective genetic study of complete and partial hydatidiform moles. Am. J. Obstet. Gynecol. 1991, 164:1270-1277.
23. LeGallo R.D., Stelow E.B., Ramirez N.C., et al. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization. Am. J. Clin. Pathol. 2008, 129:749-755.
24. Maggiori M.S., Peres L.C. Morphological, immunohistochemical and chromosome in situ hybridization in the differential diagnosis of hydatidiform mole and hydropic abortion. Eur. J. Obstet. Gynecol. Reprod. Biol. 2007, 135:170-176.
25. Matsui H., Sekiya S., Hando T., et al. Hydatidiform mole coexistent with a twin live fetus: a national collaborative study in Japan. Hum. Reprod. 2000, 15:608-611.
26. McConnell T.G., Norris-Kirby A., Hagenkord J.M., et al. Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am. J. Surg. Pathol. 2009, 33:1409-1415.
27. McConnell T.G., Murphy K.M., Hafez M., et al. Diagnosis and subclassification of hydatidiform moles utilizing p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am. J. Surg. Pathol. 2009, 33:805-817.
28. Merchant S.H., Amin M.B., Viswanatha D.S., et al. P57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses. Hum. Pathol. 2005, 36:180-186.
29. Messerli M.L., Parmley T., Woodruff J.D., et al. Inter and intra-pathologist variability in the diagnosis of gestational trophoblastic neoplasia. Obstet. Gynecol. 1987, 69:622-626.
30. Miller D., Jackson R., Ehlen T., et al. Complete hydatidiform mole coexistent with a twin live fetus: clinical course of four cases with complete cytogenetic analysis. Gynecol. Oncol. 1993, 50:119-123.
31. Murphy K.M., McConnell T.G., Hafez M.J., et al. Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat (STR) assay. J. Mol. Diagn. 2009, 11:598-605.
32. Murphy K.M., Ronnett B.M. Molecular analysis of hydatidiform moles: utilizing p57 immunohistochemistry and molecular genotyping to refine morphologic diagnosis. Pathol. Case Rev. 2010, 15:126-134.
33. Paradinas F.J., Browne P., Fisher R.A., et al. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology 1996, 28:101-110.
34. Popiolek D.A., Yee H., Mittal K., et al. Multiplex short tandem repeat DNA analysis confirms the accuracy of p57KIP2 immunostaining in the diagnosis of complete hydatidiform mole. Hum. Pathol. 2006, 37:1426-1434.
35. S. Sarmadi, N. Izadi-Mood, A. Abbasi, et al., p57KIP2 immunohistochemical expression: a useful diagnostic tool in discrimination between complete hydatidiform mole and its mimics, Arch. Gynecol. Obstet., 283 (2011) 743-748.
36. Schorge J.O., Goldstein D.P., Bernstein M.R., et al. Recent advances in gestational trophoblastic disease. J. Reprod. Med. 2000, 45:692-700.
37. Szulman A.E., Surti U. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am. J. Obstet. Gynecol. 1978, 132:20-27.
38. Zhang P., Liégeois N.J., Wong C., et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicate a role in Beckwith-Wiedemann syndrome. Nature 1997, 387:151-158.